Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
Bachelot, T, Ciruelos, E, Schneeweiss, A, Puglisi, F, Peretz-Yablonski, T, Bondarenko, I, Paluch-Shimon, S, Wardley, A, Merot, J -L, du Toit, Y, Easton, V, Lindegger, N, Miles, DLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz061
Date:
February, 2019
File:
PDF, 1.38 MB
english, 2019
File converter
More search results
More benefits 
